We’re solving the gap between AI demand and semiconductor supply with an ultra high-speed multi-chip processor, packaging a photonics chip with standard electronics. This will usher in a new era of processing where supercompute AI becomes ubiquitous.
Vaysh Kewada, CEO and Co-founder
We're enabling the rapid deployment of machine learning models so organisations can tackle their most important challenges. CIC's deep tech expertise and commercial acumen is the ideal support for our mission.
Alex Housley, Founder and CEO
Clive Cox, CTO
We focus on developing life science companies which are built to succeed. We’re excited to have founding investor CIC support us and our emerging world class businesses.
Jason Mellad, CEO
Daniel Rooke, COO
By working with GaN, I want to make an impact - an impact on society, on the people, on the employees' life, on the new generation. Thanks to CIC’s support and their knowledge of the semiconductor market, CGD will be able to expand its product portfolio, establish a presence in the US, and increase its market share to maximise the impact of the technology worldwide.
Giorgia Longobardi, Founder & CEO
CIC’s support has enabled Riverlane to become a globally leading software and algorithm company in the rapidly emerging field of quantum computing
Leonie Mueck, Chief Product Officer
Steve Brierley, CEO and Founder
Bek Simmons, Chief Operating Officer
CIC’s approach is a great fit with PragmatIC’s unique flexible electronics platform and vision towards trillions of smart objects
Scott White, CEO
CIC’s investment has helped us in our ambition to develop a transformational medicine for the treatment of pulmonary artery hypertension
Wei Li, Co-Founder
PetMedix develops antibody therapeutics for dogs and cats. CIC’s investment enables us to accelerate our program to make the drugs our pets need and deserve
Tom Weaver, CEO
Jolyon Martin, Head of Business Development
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem.
Cambridge Innovation Capital invests in some of the most exciting, forward-thinking companies across the technology and life sciences sectors.
CIC is a signatory of PRI (Principles for Responsible Investment) and the Investing In Women Code and a founding partner of LSX Female Founders.
PRI works to understand the investment implications of ESG factors and to support its international network of investor signatories in incorporating these factors into their investment.
The Investing in Women Code is a commitment by financial services firms to the advancement of female entrepreneurship through improving female entrepreneurs’ access to tools, resources and finance.
LSX Female Founders was founded to connect women entrepreneurs in the health and life science field with investors as well as offer mentorship from relevant industry professionals. Together with our fellow founding partners we can offer a combined network of over 10,000 investors to support the progression of new businesses.
CIC is a Carbon Neutral Business.
